Mueller, Christoph http://orcid.org/0000-0001-9816-1686
Rajkumar, Anto P.
Wan, Yi Min
Velayudhan, Latha
ffytche, Dominic
Chaudhuri, Kallol Ray
Aarsland, Dag
Funding for this research was provided by:
National Institute for Health Research
Article History
First Online: 20 July 2018
Compliance with ethical standards
:
: This article represents independent research partly funded by the National Institute for Health Research (NIHR) Biomedical Research Unit for Dementia in South London and Maudsley National Health Service (NHS) Foundation Trust and King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
: K Ray Chaudhuri has consulted and served on advisory boards for Britannia, AbbVie, Neuronova, Mundipharma and UCB, and has also served on advisory boards for Synapsus and Medtronic. He has received honoraria from Boehringer Ingelheim, GlaxoSmithKline, AbbVie, Britannia, UCB, Mundipharma, Otsuka and Zambon, and grants from Boehringer Ingelheim, GlaxoSmithKline, Britannia, AbbVie, UCB and Neuronova. He holds intellectual property rights for the KPP scale and the PDSS, and receives royalties for the booksNon-Motor Symptoms of Parkinson’s DiseaseandFastfacts: Parkinson’s Disease. Dag Aarsland has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals, GE Health, Easi and Heptares, and serves as a paid consultant for H. Lundbeck and Axovant. Christoph Mueller, Anto P. Rajkumar, Wan Yi Min, Latha Velayudhan and Dominic ffytche have no conflicts of interest directly relevant to the content of this article.